Calls for Proposals FY 2022 Awarded PMs under Moonshot Research and Development Program (2nd Proposal)

Outline

Status of Grants/Funding Opportunities Awarded projects
R&D phase Basic Study, Applied Study, Nonclinical Study/Pre-clinical Study, Clinical Study, Clinical Trials, None
Key Fields Moonshot Research and Development Program
Contact
Office of Project Management
-Division of Moonshot Research and Development Program
E-mail: moonshot"AT"amed.go.jp
Remarks:
※Please specify the title of e-mail with “Inquiry for the 2nd proposal”
※Please replace “AT” with “@” in the e-mail address.
※Your inquiries will be accepted only by e-mail. Please contact the address above.

Adoption contents

Regarding FY2022 the Public Offering for the 2nd Proposal of Moonshot Research and Development Program (solicitation period 2022.3.7 – 2022.5.10), Japan Agency for Medical Research and Development (AMED) conducted strict and fair deliberation by the evaluation committee. And as a result of the evaluation, AMED decided project managers to adopt for the projects as follows:

Moonshot Goal: The research and development on Target 2 (Realization of medical networks accessible for anyone from anywhere in the world)
Research and Development Project PM Affiliation Position
Bring hospital into home toward controlling inflammation at home NANGAKU Masaomi  The University of Tokyo Professor
Moonshot Goal: The research and development towards novel approach (Example: Intestinal flora, etc.)
Research and Development Project PM Affiliation Position
Understanding and harnessing the role of the gut microbiome in healthy longevity HONDA Kenya Keio University Professor

Evaluation Process

Solicitation Period 2022.3.7 Mon – 2022.5.10 Tue
Evaluation Committee 2022.7.20 Wed
The research and development on Target 2
Number of applicants received 14
Number of proposals interviewed 3
Number of proposals selected for funding 1
 
The research and development towards novel approach
Number of applicants received 9
Number of proposals interviewed 2
Number of proposals selected for funding 1

09/30/22

Last updated 09/30/22